BlackRock’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17M Buy
4,238,410
+3,181,392
+301% +$12.7M ﹤0.01% 3086
2025
Q1
$3.36M Sell
1,057,018
-15,923
-1% -$50.6K ﹤0.01% 3758
2024
Q4
$5.74M Buy
1,072,941
+469,064
+78% +$2.51M ﹤0.01% 3619
2024
Q3
$3.19M Buy
603,877
+41,853
+7% +$221K ﹤0.01% 3809
2024
Q2
$1.02M Buy
562,024
+39,046
+7% +$71.1K ﹤0.01% 4121
2024
Q1
$931K Buy
522,978
+2,427
+0.5% +$4.32K ﹤0.01% 4157
2023
Q4
$916K Sell
520,551
-700
-0.1% -$1.23K ﹤0.01% 4212
2023
Q3
$761K Sell
521,251
-11,130
-2% -$16.3K ﹤0.01% 4248
2023
Q2
$1.22M Buy
532,381
+39,159
+8% +$89.7K ﹤0.01% 4151
2023
Q1
$449K Buy
493,222
+2,441
+0.5% +$2.22K ﹤0.01% 4470
2022
Q4
$417K Sell
490,781
-12,161
-2% -$10.3K ﹤0.01% 4573
2022
Q3
$411K Sell
502,942
-2,624
-0.5% -$2.14K ﹤0.01% 4693
2022
Q2
$501K Buy
505,566
+6,092
+1% +$6.04K ﹤0.01% 4684
2022
Q1
$819K Sell
499,474
-7,798
-2% -$12.8K ﹤0.01% 4639
2021
Q4
$1.22M Buy
507,272
+406,821
+405% +$981K ﹤0.01% 4530
2021
Q3
$486K Sell
100,451
-30,477
-23% -$147K ﹤0.01% 4695
2021
Q2
$350K Buy
130,928
+53,260
+69% +$142K ﹤0.01% 4708
2021
Q1
$239K Buy
77,668
+7,858
+11% +$24.2K ﹤0.01% 4651
2020
Q4
$248K Sell
69,810
-91,739
-57% -$326K ﹤0.01% 4365
2020
Q3
$647K Sell
161,549
-148,933
-48% -$596K ﹤0.01% 4114
2020
Q2
$844K Sell
310,482
-4,795
-2% -$13K ﹤0.01% 4001
2020
Q1
$664K Buy
315,277
+1,440
+0.5% +$3.03K ﹤0.01% 3919
2019
Q4
$1.71M Sell
313,837
-20,259
-6% -$110K ﹤0.01% 3775
2019
Q3
$1.01M Buy
334,096
+1,162
+0.3% +$3.5K ﹤0.01% 3929
2019
Q2
$1.24M Sell
332,934
-589,026
-64% -$2.2M ﹤0.01% 3894
2019
Q1
$3.71M Sell
921,960
-24,418
-3% -$98.2K ﹤0.01% 3482
2018
Q4
$3.47M Sell
946,378
-260,142
-22% -$955K ﹤0.01% 3478
2018
Q3
$10.4M Buy
1,206,520
+87,013
+8% +$746K ﹤0.01% 3193
2018
Q2
$12.3M Buy
1,119,507
+382,389
+52% +$4.2M ﹤0.01% 3106
2018
Q1
$8.5M Buy
737,118
+67,461
+10% +$778K ﹤0.01% 3174
2017
Q4
$6.94M Buy
669,657
+289,096
+76% +$2.99M ﹤0.01% 3282
2017
Q3
$6.07M Buy
380,561
+11,359
+3% +$181K ﹤0.01% 3356
2017
Q2
$4.47M Buy
369,202
+190,584
+107% +$2.31M ﹤0.01% 3452
2017
Q1
$3.71M Buy
178,618
+178,380
+74,950% +$3.7M ﹤0.01% 3441
2016
Q4
$3K Sell
238
-200
-46% -$2.52K ﹤0.01% 3516
2016
Q3
$7K Buy
438
+238
+119% +$3.8K ﹤0.01% 3385
2016
Q2
$3K Sell
200
-11,800
-98% -$177K ﹤0.01% 3530
2016
Q1
$174K Buy
+12,000
New +$174K ﹤0.01% 1720